Prader-Wdli syndrome (PWS) is a developmental disorder characterized by mental retardation or learning disability, infantile hypotonia and poor suck reflex, growth retardation, delayed sexual development, and the childhood onset of pronounced hyperphagia Food-related difficulties are the most striking and widely recognized sequelae of this syndrome. Without appropriate dietary and behavioral intervention, almost everyone with PWS will become dangerously obese. However, in addition to these well-known problems with food, those with PWS also suffer from a range of psychiatric and behavioral difficulties, including high rates of depression, obsessions, and compulsions.
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Flg. 1 An idcogram of chromosomc 15 (Icfr) and a rcprcscntation of thc approximatcly 4 million base pair region most commonly dclctcd in paticnts with Pradcr-Willi syndromc (PWS) or Angclman syndrome (AS) (right). Thc diagram is not to d c . Multiplc gcncs containcd within the commonly dclctcd region arc shown by thc small boxcs containcd within thc v c n i d bar. Thcsc gcnes include a zinc finger protein (zhrFL?7), nccdin (NDN), small nudear ribonudeoprotein associated polypcptidc upstrcam reading frame (SNURF), small nuclear ribonuclcoprotcin associated polypcptidc N (SNRPN), imprintcd in thc Pradcr-Willi rcgion (IPW), %AP ubiquitin ligvc (UBBA), 3 y-aminobutyric acid rcccptor subunits (GABRB3, A5. and G3), thc human onhologue of thc m o w pink cycd dilution locus (P) locus, and H E R O (for HEct domain and RCcl domain protein 2). As noted on the far right of thc figurc, thc first 5 of thcsc gcncs arc patcrnally cxprcsscd. UBBA is matcmally cxprcsscd. and thc othcr gcna am cxprcsscd from both chromosomes. Givcn rhc similarities between thc phcnocypcs that result from abnormalities in imprinting and thosc that rcsult from dclctions, it is unlikcly that thc nonimprintcd gcncs in the rcgion play a substantial role in P W S or AS. As notcd in thc tcxt, a specific gcnc responsiblc for PWS has not yct becn identified. Morcovcr. thc list of transcripts in this rcgion remains a work in progrcsr, and it remains probable that scvcral gcnes togcthcr contribute to thc d i n i d phcnotypc. In contrast. mutations in a single gcnc, UBBA. havc bcen found to cause somc c a m of Angclman syndrome.
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opposed to familial) loss of chromosomal material in the region 15qll-ql3 leads to the predictable clinical phenotype. However, a closer look suggests that there is considerable subtlety and complexity to the genetic mechanisms involved. At first, geneticists were baffled by the observation that AS is caused by a deletion involving the same chromosomal region in which PWS is involved. The relationship between the two syndromes was particularly unexpected because of the absence of any significant clinical overlap between the two, with AS leading to severe m e n d retardation, seizures, and the absence of language.
By the mid-198Os, it had become clear that the key to the genetic distinction between PWS and AS was the parental origin of the chromosome containing the deletion. In PWS, the deletion is always found on the paternally donated chromosome. Conversely, in AS, the deletion is always located on the maternally donated chromosome. This discovery led to the recognition that gene expression in humans may be dictated by the chromosome on which the particular copy of that gene resides. This phenomenon, known as genomic imprinting, has been discussed in greater detail in 2 recent columns.
Over the past decade, researchers discovered that PWS may result not only from a chromosomal deletion, but also from maternal uniparental disomy (UPD). In this situation, 2 copies of the maternal chromosome are inherited with no paternal contribution. In the normal circumstance, the paternally donated chromosome expresses multiple genes in the PWS region, while the maternal chromosome is largely silent. In the case of UPD, without the presence of a chromosome donated from the hther, normal imprinting on the 2 maternally donated chromosomes leads to the absence of gene expression in this interval. As a result, despite the presence of 2 intact chromosomes, there is afirndonalabnormality that is largely equivalent to the structural abnormality found in the more common 15qllq13 deletions. In addition, in about 5% of afFected individuals, abnormalities in the mechanism of imprinting may lead to the absence of gene expression from the paternally donated chromosome, resulting in the PWS phenotype. This occurs when the imprinting control center is itself mutated. The specific genes in the 15qll-q13 region that result in the various manifestations of PWS have not yet been identified. The small nuclear ribonucleoprotein associated polypeptide N (SNRPN) has been the object of considerable study. This gene is involved in protein splicing, it is expressed throughout the brain, and its promoter resides within the smallest chromosomal region of overlap among all deletions leading to PWS.
However, findings from animal knockouts and rare cases of chromosomal rearrangements in humans have suggested that the PWS phenotype may not be the direct result of a loss of SNRPN expression. A number of other candidate genes have been identified as well, including the neuronal protein, necdin (NDN). This gene, when knocked out, leads to failure-tothrive in certain strains of mice, a phenotype that is clearly analogous to the poor suck reflex and failure-to-thrive seen in infants with PWS. It is interesting that knockout mice that survive these initial difficulties go on to develop normally. Figure 1 illustrates the genes contained within the PWSIAS region.
There has long been speculation that the genetic abnormal- Despite the multiple signs pointing in the direction of the hypothalamus, several studies have identified other brain regions and neuropeptides as possibly being involved in PWS. A study that included both MRI and magnetic resonance spectroscopy showed d i k minor abnormalities in subjects versus controls, including slightly enlarged ventricles, cortical atrophy, and a small brainstem. In addition, there has been a report of abnormalities in plasma y-aminobutyric acid (GABA) in PWS sub jects. This neurotransmitter has been the subject of some interest, because loci fix GABA receptor subunits are located in the vicinity of 15qllq13, just telomeric to the PWSIAS critical region.
For those who are not familiar with the syndrome, it may be difficult to grasp just how profound and far-reaching chronic hyperphagia is for those with PWS and their loved ones.
Hoarding food is common, as is stealing or sneaking to circumvent dietary restrictions. Without significant intervention, which often indudes lodung cabinets and refrigerators, almost everyone with PWS will become obese. Given the combination of poor musde tone, small stature, and a driven appetite, the extent of this obesity may readily become life-threatening. During childhood and into adolescence, resuictions on food may lead to constant conflicts, and parents and other caregivers are often in the &cult position of having to enforce diets that would leave a person of normal appetite feeling constantly hungry.
If this difficulty with food were not a sufficient hurdle, persons with PWS also suffer from a range of behavioral and psychiatric difficulties apart from food, including obsessions, compulsions, mood lability, and depression, which may often be quite severe. While children and adolescents with PWS have, on average, mild levels of cognitive delay, their behavioral and psychiatric difficulties typically result in highly restrictive levels of care and are often the source of enormous distress for patients and their families.
These types of difficulties have been the subject of a growing body of research over the past decade. Conventional clinical wisdom as well as descriptive studies have long held that some personality characteristics and psychiatric difficulties observed in those with PWS are in fact a distinctive feature of the syndrome, a so-called "behavioral phenotype." As the number of well-controlled investigations into the adaptive and psychological functioning of those with PWS has grown, this clinical folklore has been largely substantiated by experimental data.
The notion that those with PWS have a distinctive behavioral phenotype is nonetheless still somewhat controversial.
There is an understandable reluctance on the part of clinicians and researchers to paint a group of individuals with an overly broad brush. However, in the case of PWS, several carefully done studies have identified both a set of behaviors and personality attributes that do, on average, distinguish those with the syndrome from other developmentally delayed individuals with and without clearly identified genetic syndromes. The concept of a behavioral phenotype may be difficult to accept if it is taken as a description of every person with a syndrome. A more useful definition is that a behavioral phenotype is simply a heightened probability that people with a given syndrome will exhibit behavioral or developmental characteristics relative to others without the syndrome. For example, hyperphagia is not unique to persons with PWS, and not everyone with the syndrome exhibits it. However, the odds are that a I-year-old with PWS will develop this difficulty in the succeeding 3 years.
Several recent studies demonstrate that such a heightened probability dearly applies to obsessions and compulsions apart from the issues around food. A study in the mid-1990s showed that more than 60% of PWS subjects had obsessive-compulsive symptoms with moderate to severe levels of symptom-related distress and adaptive impairment. More than half of subjects met clinical criteria for obsessive-compulsive disorder (OCD).
Their symptoms were of similar type and severity to those found in persons with OCD without mental retardation. Two subsequent studies supported thcse data and demonstrated that increased obsessive-compulsive symptomatology could not be easily accounted for by rater bias, obesity, or even hyperphagia Recent studies have compared those with PWS to other groups with genetic syndromes as well as those with mental retardation of mixed etiology. Overall, those with PWS appear to have more behavioral disturbances than controls, including tantrums, irritability, and agitation. Those with PWS also seem likely to have skin-picking, repetitive speech, and "underactivity." There have been numerous observations that those with PWS suffer from both depression and anxiety, although controlled studies regarding depressive and anxious symptoms (apart from OCD) have yet to be conducted.
The PWS behavioral phenotype is not limited to psychiatric and behavioral difficulties. Many individuals with PWS also show a distinctive, although not necessarily unique, profile of cognitive strengths and weaknesses. Those with the disorder span a large range of intelligence, from average ability to severe retardation. The mean I Q is 70, which is high relative to that found in other genetic mental retardation syndromes. Adaptively, however, even those with normal I Q rarely function at a level commensurate with this measure of intelligence, usually because of interference from the food-related and other behavioral problems. Academically, reading/decoding and comprehension may exceed arithmetic skills, although academic performance may not be sufficiently uneven to meet learning disability criteria. Some people with PWS have relative strengths in spatial-perceptual organization and visual processing. By contrast, weaknesses have commonly been noted in sequential processing and short-term memory tasks, including visual, motoric, and auditory short-term memory.
In summary, research into PWS over the past decade has begun to establish some links between genetic abnormalities, brain function, and behavioral and cognitive attributes. Genes in the region of 15qll-13 may be abnormally expressed as the result of either a structural or functional abnormality in this chromosomal region. Although the specific genetic culprits have not yet been identified, the genetic lesion(s) appear to lead to hypothalamic dyshction. Finally, the accumulated evidence suggests that whatever the underlying neuropathology, those with PWS often display some evidence of a behavioral phenotype that clearly includes obsessive-compulsive symptoms, skinpicking, hyperphagia, low activity levels, behavioral outbursts, and a distinctive cognitive profile compared to controls with mental retardation.
This emerging picture of gene-brain-behavior relationships suggests a range of important research questions. For instance, is the hypothalamus the key brain region affected by the gene or genes underlying the behavioral aspects of PWS? What roles do the hypothalamus and hypothalamic peptides play in the rituals, obsessions and compulsions, and mood lability often seen in those with PWS? Does this brain region contribute to similar manifestations in those without PWS? Are all persons with PWS, regardless of the underlying genetic mechanism, equally STATE AND DYKENS likely to display aspects of the behavioral as well as physical and developmental phenotype?
As these questions are answered, it is likely that avenues for improved treatment will reveal themselves. More broadly, this view of how genes, brain, body, and mind interact will provide some unexpected clues about the roots of psychopathology in other psychiatric conditions.
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